FINWIRES · TerminalLIVE
FINWIRES

S&Pグローバル:原油価格の急落がアジア太平洋地域の債券市場を弱体化させる可能性

-- S&Pグローバルは木曜日、ペルシャ湾戦争と原油価格の高騰が続けば、アジア太平洋地域の社債発行残高の約7分の1が圧力にさらされる可能性があると報告した。 「長期にわたる原油価格ショックは、下方シナリオで評価したアジア太平洋地域の格付け対象企業の15%の信用力を損なう可能性がある」とS&Pグローバルは指摘した。「これは、戦争が早期に終結するという基本シナリオにおける9%から上昇している」。 S&Pグローバルは、アジア太平洋地域は他の多くの地域よりも中東関連のエネルギーショックの影響を受けやすく、「エネルギーおよび原材料供給の混乱、需要の減少、利益率の低下、運転資金の変動」に対して脆弱であると警告した。 同格付け機関は、ホルムズ海峡を通過する原油の約90%がアジア向けであり、ペルシャ湾産原油はアジア太平洋地域のエネルギー輸入の約40%を占めていると指摘した。 S&Pグローバルは、アジアにおいてジェット燃料、ディーゼル燃料、液化石油ガス(LPG)に依存する産業や企業が「最も高い供給不足リスクに直面している」と報告した。 最も影響を受ける業種は、化学、石油・ガス下流部門、航空会社、自動車製造、エンジニアリング・建設、建築資材などである。 国別に見ると、韓国、日本、中国本土は十分な備蓄を活用することで「短期的な供給途絶をほぼ回避している」が、「他の国々は潜在的なエネルギー供給逼迫に対処するため、様々な対策を発表せざるを得なくなっている」とS&Pグローバルは述べている。 高価格が続けば、企業だけでなく一部の国債も影響を受ける可能性がある。 S&Pグローバルによると、フィリピンのソブリン格付けは先週、原油価格ショックへのエクスポージャーを理由に「ポジティブ」から「安定的」に引き下げられた。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB